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THE RHEUMATOID FACTOR
by W. R. M. ALEX AN D ER
Rheum atic Diseases Unit, Northern G eneral Hospital. Edinburgh
H ISTO RICAL
T h e observation that certain human sera had 
the property of agglutinating sheep erythrocytes 
previously sensitized with specific antibody has 
been made sporadically since the turn of the 
century. O nly in 1940, however, was this 
property shown to belong, in the main, to sera 
from patients suffering from rheumatoid 
arthritis. In that year, W aaler,(1) working in 
Scandinavia, published a paper drawing atten- 
tion to the phenomenon and described a sero- 
logical test claimed to be useful in the diagnosis 
of rheumatoid arthritis. Because of the diffi- 
culties of communication in war-time, W aaler’s 
work remained largely unknown. I n 1948, Rose 
and his colleagues(21) in N ew  York, unaware 
of W aaler’s observations, “ rediscovered”  the 
phenomenon and described a diagnostic test, 
similar in principle to W aaler’s. T h e observ- 
ations of W aaler and of Rose and his colleagues 
have now been amply confirmed and the Rose 
W aaler test, or more usually one of the numer- 
ous modifications thereof, is used routinely as 
a diagnostic aid in rheumatoid arthritis.
THE ROSE W A ALE R  TEST AND  ITS DERIVATIVES
In the original test, com plem ent is removed 
from the test serum by heating at ;6 °C . for 
thirty minutes. D uplicate serial dilutions of the 
serum are made and to one set of dilutions 
sheep erythrocytes, previously washed in saline, 
are added. Th is titration gives some measure 
of the concentration of heterophil agglutinins 
which are almost invariably present in human 
sera. T o  the other set of dilutions, sheep 
erythrocytes which have been sensitized with a 
sub-agglutinating dose of rabbit anti-sheep 
erythrocyte serum are added.*
After a period of incubation at 3 7 °C . the 
titre  of the test serum for non-sensitized and 
sensitized sheep erythrocytes is read. As an 
example, using serum from a healthy subject 
the titre for non-sensitized sheep cells might 
be 1 : 32 and that for sensitized sheep cells 1 :  64. 
In expressing the result of the test the recipro­
cal of the titre for sensitized cells is divided 
by the reciprocal of the titre for non-sensitized 
cells, in this instance, 64 divided by 32 =  2. 
T h e  quotient is called the differential agglu- 
tination titre or D .A .T . A  D .A .T . of 8 or more 
is generally taken to be a positive test indic- 
ating that in rheumatoid arthritis the titre of 
the serum for sensitized cells usually greatly 
exceeds the titre for non-sensitized cells. This 
original test is technically satisfactory, but 
suffers from the drawback that a “ false negative”  
Result may be obtained in a patient with 
rheumatoid arthritis if a high titre of heterophil 
agglutinins is present.
B a ll3) in 1950, proposed a modification to 
the original test to overcome this difficulty. In 
his test, the serum is first absorbed with non- 
sensitized cells to remove heterophil agglutinins 
and then titrated with sensitized cells. T h e 
result is expressed as the true titre for sensitized 
cells. Mis method is now generally preferred to 
the original Rose W aaler method and the test 
has become known as the sensitized sheep cell 
test, S .S .C .T . or sheep cell agglutination test, 
S .C .A .T .
* The dose required fo r sensitization is previously 
determined by titrating the anti-serum with sheep 
erythrocytes; thus, i f  the sheep erythrocytes are agglu- 
tinated to a titre o f 1 : 1000, which would then be the 
aggultinating dose, erythrocytes fo r use in the test 
would be sensitized by exposing them to one-quarter 
or one-half o f this dose, namely anti-serum diluted 
to 1 : 4000 or 1 : 2000.
There have been many attempts to increase 
the specificity and sensitivity of the S .S .C .T ., 
but, in general, it can be said that so far as 
practical tests for use in a routine laboratory 
are concerned, any increase in sensitivity is off­
set by a decrease in specificity.
C LIN ICA L ASSO CIATIO NS OF THE SEN SITIZED  
SHEEP C ELL T EST
R heum atoid Arthritis. T h e test is positive 
in about 65. to 70 per cent of patients with 
adult rheumatoid arthritis. Unfortunately, 
from the diagnostic point of view, the incid- 
ence is considerably lower in patients in whom 
the duration of the disease is less than one 
year and in whom certain other stigmata of 
rheumatoid arthritis, such as the presence of 
radiographic erosions or of subcutaneous 
nodules, are absent.
Prospective studies have shown that about 
one-third of patients remain sero-negative 
throughout the course of the disease, a further 
third may fluctuate from positive to negative 
and a third remain consistently sero-positive.
Polyarthritis, other than R heum atoid  
Arthritis. T h e  incidence of positive tests in 
juvenile rheumatoid arthritis (Still’s disease) 
is low, ranging from about 7 to 15  per cent. 
Patients with ankylosing spondylitis, Reiter’s 
disease, rheumatic fever, psoriatic arthritis, etc. 
arc generally sero-negative, the incidence of 
positivity being little greater than in the popul- 
ation as a whole. T h e  incidcnce of scro- 
positivity in other members of the group of 
inflamm atory diseases of connective tissue, 
(including disseminated lupus erythematosus, 
progressive systemic sclerosis, polyarteritis 
nodosa and dermatomyositis), is difficult to 
establish in view of the clinical overlap between 
these conditions and rheumatoid arthritis. 
Sero-positivity is most likely to occur in cases 
of these diseases in which polyarthritis is a 
prom inent manifestation.
O ther diseases and healthy subjects. In most 
reported series, the incidence of sero-positivity 
in diseases outwith the connective tissue group 
is around 4 to 5 per cent, this being no higher 
than in the population as a whole. ’  There are, 
however, notable exceptions. Positive tests 
are frequently; recorded during the active phase 
of sub-acute bacterial endocarditis. T h e  test is 
also postive in about 30 per cent of patients
with leprosy and in a smaller proportion of 
patients suffering from the rather obscure 
group of diseases characterised by dysgamma- 
globulinaeinia.
About 5 per cent of apparently healthy 
individuals are sero-positive, but a higher figure 
is reported in the relatives of patients suffering 
from sero-positive rheumatoid arthritis. This 
latter observation has been advanced in support 
of there being a genetic factor in the patho­
genesis of rheumatoid arthritis, but could 
equally be accounted for by an environmental 
factor.
THE NATURE OF THE FACTOR R E SPO N SIBL E FOR
AGGLUTINATION OF SEN SITIZED  SHEEP
ER YTH RO C YTE S
Rheumatoid factor (R.F1'.) has now been 
characterised by physicochemical methods. 
Th e factor has been shown to be a high mole- 
cular weight globulin belonging to the im m uno- 
globulin M  (IgM ) class. It is most frequently 
detected in serum, but may also be present in 
synovial fluid and in other serous effusions in 
patients with rheumatoid arthritis. Using 
immuno-chemical methods, R .F . has been 
demonstrated in plasma cells in synovial mem- 
brane and in lym ph nodes. It has many of the 
characteristics of an antibody and forms com - 
plexes with globulins of the immuno-globulin 
G  (IgG ) class, provided that the Ig G  has been 
denatured by physical or chemical means or, 
in the case of antibody IgG , combined w ith 
its specific antigen. O n the basis of animal 
experiments, G lynn, Holborow and Johnson*41 
in 1957, suggested that R .F . reacted with sites 
on the gammaglobulin molecule which only 
became revealed when the molecule was de­
natured.
W h en  the globulins in the serum of a patient 
with scro-positive rheumatoid arthritis are 
separated by ultra-centrifugation, precipitation 
will only rarely occur when the Ig G  and IgM  
fractions are recombined. If, however, the IgG  
fraction is heated at 6 o°C . for ten minutes, and 
is then added to the IgM  fraction .(which con- 
tains rheumatoid factor), precipitation occurs. 
On the basis of this experiment, it has. been 
suggested that rheumatoid factor is not only an 
antibody but an auto-antibody. There is, how- 
ever, no clear-cut evidence that rheumatoid 
factor combines with native -gammaglobulin 
in vivo.
T h e ability of rheumatoid factor to precipit- 
ate with denatured IgG  forms the basis of the
latex fixation test (L .F .T .) . L atex  particles 
coated w ith denatured hum an Ig G  are clum ped 
by scrum  contain ing R .F . T h e  L .F .T . is sim ple 
to do and is m ore sensitive than the S .S .C .T . 
but is, however, less specific for rheum atoid 
arthritis.
P O S S I B L E  P A T H O G E N I C  S I G N I F I C A N C E  OF T H E  
R H E U M A T O I D  F A C T O R
There is now  a considerable body of opinion 
w hich favours the view  that rheum atoid 
arthritis is an auto-im m une disease. T h is  is not 
the place to discuss the m erits and dem erits of 
such a hypothesis but rather to exam ine the 
possible role o f R .F . in the pathogenesis o f the 
disease.
It seem s reasonable to suppose that R .F . is 
produced by the im m une system  in response 
to stim ulation by the presence in tissues of 
m ild ly altered Ig G . T h ere  is evidence that Ig G  
is present in the synovial lesion and it has been 
suggested th at its presence indicates an im m une 
reaction, possib ly o f fundam ental im portance, 
occurring in the synovium . I f  such a reaction 
should be dem onstrated in the future, it is 
likely that it w ill be show n to be of th e  cell- 
m ediated or delayed hypersensitivity type, for 
it is w ith this type of im m une reaction that 
the histological appearances in the synovial 
m em brane arc m ost com patible.
T h e  suggestion that R .F . is not responsible 
for the synovial lesion in rheum atoid disease 
is borne out by a num ber of observations. In 
19 59, V augh an  and H arris5 transfused high- 
titre rheum atoid serum to other patients with 
the disease and failed to  prom ote exacerbation 
o f sym ptom s. A lso, rheum atoid factor has been 
show n, som etim es in high titre, in unaffected 
relatives o f patients w ith rheum atoid arthritis 
and, from  tim e to tim e, in th e sera o f appar­
ently healthy subjects. H istologically, it is 
im possible to distinguish betw een se ro-positive 
and sero-negative arthritis. An arthritis, very 
sim ilar to rheum atoid arthritis, occurs in 
patients suffering from  hypogam m aglobulin- 
aem ia but no R .F . is found in the sera of these 
patients. D u th ie , B row n, K nox and T h om p- 
so n ,6  in a study of the prognosis o f rheum - 
atoid arthritis, showed that patients w ho were 
consistently sero-positive fared worse than their 
se ro-negative fellow s. It can be suggested from 
this that in patients w ith continu ing active 
disease, the stim ulus to the production of R .F . 
by the prim ary synovial lesion is con stan tly 
present.
A lthough in the m ain, the evidence is that 
R .F . is an indicator, rather than m ediator, o f 
the prim ary lesion, there is one m anifestation 
o f rheum atoid disease w hich could be caused 
by circulating R .F . It has been show n in exper­
im ental anim als that in jection  o f com plexes of 
R .F . and denatured Ig G  into the m esenteric 
vessels m ay be fo llow ed by deposition o f com - 
plexes in the term inal vessels, thus producing 
a vasculitis. It seem s possible that a sim ilar 
m echanism  m ight account for the vascular 
lesions seen in som e patients w ith rheum atoid 
arthritis, particularly as it is com m on to find a 
very high titre of R .F . in such patients.
F in ally , although our know ledge of the 
pathogenic significance of R .F . is incom plete, 
tw o  observations m ay give a lead to the aetio- 
logy of rheum atoid arthritis. T h e  first, already 
m entioned, is the high incidence o f R .F . in a 
few  diseases of know n in fective  aetiology and 
the second is the dem onstration of Abruzzo 
and C h ristian 17' that an “ R .F .-lik e "  substance 
m ay be detected in th e serum o f anim als 
hypcrim m un ised w ith dead bacteria.
T h ese  observations, taken w ith the obvious 
co m p atib ility  o f the clinical features and course 
o f rheum atoid arthritis w ith  a chronic in fect- 
ious illness, have re-awakened interest in the 
search for an exogenous living antigen in the 
synovial m em brane. O ver the past few  years a 
num ber of centres have reported isolation of 
a variety o f in fective agents from  rheum atoid 
tissues. A lthough none o f these agents has 
been causally im plicated in the disease, there 
is now  enough circum stantial evidence to 
extend this type of investigation. Should  it 
eventually be established that rheum atoid 
arthritis is caused by a virus, m ycoplasm a or 
bacterium  (or any com bination o f the three!) 
then hopes o f a “ cure”  w ould be revived and 
those w ho find it difficult to believe that 
individuals turn against them selves —  at least 
w ithout som e outside stim ulus —  w ould be 
satisfied.
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